{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:40:18Z","timestamp":1766086818466},"reference-count":20,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"DOI":"10.1210\/jc.2012-4144","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:51:50Z","timestamp":1362703910000},"page":"E723-E726","source":"Crossref","is-referenced-by-count":13,"title":["Atypical Femoral Fractures Shortly After Osteonecrosis of the Jaw in a Postmenopausal Woman Taking Alendronate for Osteoporosis"],"prefix":"10.1210","volume":"98","author":[{"given":"Wei-Yih","family":"Chiu","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism (W.-Y.C., K.-S.T.), Department of Internal Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan"},{"name":"Department of Laboratory Medicine (W.-Y.C., K.-S.T.), National Taiwan University Hospital, Taipei 10002, Taiwan"},{"name":"Graduate Institute of Clinical Medicine (W.-Y.C.), College of Medicine, National Taiwan University, Taipei 10002, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jang-Jaer","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Oral and Maxillofacial Surgery (J.-J.L.), Department of Dentistry, National Taiwan University Hospital, Taipei 10002, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keh-Sung","family":"Tsai","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism (W.-Y.C., K.-S.T.), Department of Internal Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan"},{"name":"Department of Laboratory Medicine (W.-Y.C., K.-S.T.), National Taiwan University Hospital, Taipei 10002, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113401039000_B1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113401039000_B2","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113401039000_B3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113401039000_B4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00520-005-0913-5","article-title":"Bisphosphonates for malignancy-related bone disease: current status, future developments","volume":"14","author":"Body","year":"2006","journal-title":"Support Care Cancer"},{"key":"key\n\t\t\t\t2019041113401039000_B5","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJM199612123352409","article-title":"Bisphosphonates in the treatment of bone diseases","volume":"335","author":"Delmas","year":"1996","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113401039000_B6","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113401039000_B7","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"key\n\t\t\t\t2019041113401039000_B8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3899\/jrheum.080759","article-title":"Bisphosphonate associated osteonecrosis of the jaw","volume":"36","author":"Khan","year":"2009","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2019041113401039000_B9","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113401039000_B10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3949\/ccjm.78a.11022","article-title":"What is the optimal duration of bisphosphonate therapy?","volume":"78","author":"Ott","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"key\n\t\t\t\t2019041113401039000_B11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113401039000_B12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jbmr.1550","article-title":"Incidence and demography of femur fractures with and without atypical features","volume":"27","author":"Feldstein","year":"2012","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113401039000_B13","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1056\/NEJMc0910389","article-title":"Atypical femoral fractures and bisphosphonate use","volume":"362","author":"Girgis","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113401039000_B14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bone.2012.05.010","article-title":"Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy","volume":"51","author":"Chang","year":"2012","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113401039000_B15","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2106\/JBJS.J.01199","article-title":"Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates","volume":"93","author":"Puhaindran","year":"2011","journal-title":"J Bone Joint Surg Am"},{"key":"key\n\t\t\t\t2019041113401039000_B16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.joms.2008.11.005","article-title":"Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates","volume":"67","author":"Grasko","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"key\n\t\t\t\t2019041113401039000_B17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.mehy.2011.08.008","article-title":"Is rheumatoid arthritis a risk factor for oral bisphosphonate-induced osteonecrosis of the jaws?","volume":"77","author":"Conte Neto","year":"2011","journal-title":"Med Hypotheses"},{"key":"key\n\t\t\t\t2019041113401039000_B18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bone.2010.05.019","article-title":"Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case\/case series studies","volume":"47","author":"Giusti","year":"2010","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113401039000_B19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bone.2012.02.632","article-title":"Clinical correlates of atypical femoral fracture","volume":"51","author":"Lo","year":"2012","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113401039000_B20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00198-012-1953-6","article-title":"Osteonecrosis and atypical fractures\u2014common origins?","volume":"24","author":"Subramanian","year":"2013","journal-title":"Osteoporos Int"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/4\/E723\/9049844\/jcemE723.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T12:48:53Z","timestamp":1562762933000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/4\/E723\/2537202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-4144","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,1]]}}}